A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients
Clinical Trials
Study
GLY-200-02
Phase 2 study of safety, tolerability, and pharmacodynamic effects of GLY-200 in type 2 diabetic patients
Status:
Enrollment completed
Study
GLY-200-01
Phase 1 study of safety and tolerability of GLY-200 in healthy volunteers
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects